Cleo Robinson
Overview
Explore the profile of Cleo Robinson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
310
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hendry S, Mamotte L, Mesbah Ardakani N, Leslie C, Tesfai Y, Grieu-Iacopetta F, et al.
Pathology
. 2023 Oct;
55(7):917-921.
PMID: 37805343
Complete biomarker workup of non-small cell lung cancer (NSCLC) specimens is essential for appropriate and timely clinical management decisions. This can be challenging to achieve from small cytology and histology...
2.
Kong B, Sim H, Nowak A, Yip S, Barnes E, Day B, et al.
BMJ Open
. 2023 May;
11(12):e054075.
PMID: 37185327
Introduction: Grades 2 and 3 gliomas (G2/3 gliomas), when combined, are the second largest group of malignant brain tumours in adults. The outcomes for G2/3 gliomas at progression approach the...
3.
Marsavela G, Johansson P, Pereira M, McEvoy A, Reid A, Robinson C, et al.
Cancers (Basel)
. 2020 Dec;
12(12).
PMID: 33339135
In this study, we evaluated the predictive value of circulating tumour DNA (ctDNA) to inform therapeutic outcomes in metastatic melanoma patients receiving systemic therapies. We analysed 142 plasma samples from...
4.
Warburton L, Calapre L, Pereira M, Reid A, Robinson C, Amanuel B, et al.
Cancers (Basel)
. 2020 Nov;
12(11).
PMID: 33238616
Immunotherapy is an important and established treatment option for patients with advanced melanoma. Initial anti-PD1 trials arbitrarily defined a two-year treatment duration, but a shorter treatment duration may be appropriate....
5.
Marsavela G, Lee J, Calapre L, Wong S, Pereira M, McEvoy A, et al.
Clin Cancer Res
. 2020 Oct;
26(22):5926-5933.
PMID: 33067256
Purpose: We evaluated the predictive value of pretreatment ctDNA to inform therapeutic outcomes in patients with metastatic melanoma relative to type and line of treatment. Experimental Design: Plasma circulating tumor...
6.
Fan X, McLaughlin C, Robinson C, Ravasini J, Schelch K, Johnson T, et al.
FASEB Bioadv
. 2020 Mar;
1(9):550-560.
PMID: 32123850
Malignant mesothelioma (MM) is an almost invariably fatal cancer caused by asbestos exposure. The toxicity of asbestos fibers is related to their physicochemical properties and the generation of free radicals....
7.
Harvey N, Grewal J, Mesbah Ardakani N, Robinson C, Leecy T, Forrest C, et al.
Am J Dermatopathol
. 2019 Nov;
42(6):423-431.
PMID: 31725485
While most melanomas display well-characterised and readily recognised architectural and cytomorphological features, unusual variants can create diagnostic difficulties. Variants which mimic benign or reactive processes are particularly problematic. We report...
8.
Dessauvagie B, Thomas A, Thomas C, Robinson C, Combrink M, Budhavaram V, et al.
Pathology
. 2019 Oct;
51(7):681-687.
PMID: 31630876
Invasive lobular carcinoma (ILC) is almost always classified as Nottingham histological grade 2. Despite this, prognosis is markedly varied, with some ILCs behaving more akin to grade 3 invasive ductal...
9.
Wang M, McLaren S, Jeyathevan R, Allanson B, Ireland A, Kang A, et al.
Pathology
. 2019 Mar;
51(3):246-252.
PMID: 30850279
Ki-67 proliferative index (PI) has prognostic and predictive value in invasive breast carcinoma (IBC), but clinical uptake has been hampered by suboptimal accuracy, reproducibility and standardisation. Published guidelines have addressed...
10.
Fan X, McLaughlin C, Ravasini J, Robinson C, George A
FEBS Open Bio
. 2018 Nov;
8(11):1773-1781.
PMID: 30410857
For centuries, zeolites have been used for their utility in binding metals, and they feature in a multitude of agricultural and industrial applications in which the honeycombed zeolite structures form...